203 related articles for article (PubMed ID: 23314552)
21. Neurochemical effects of choline supplementation.
Wecker L
Can J Physiol Pharmacol; 1986 Mar; 64(3):329-33. PubMed ID: 3708441
[TBL] [Abstract][Full Text] [Related]
22. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release.
Dixon CE; Ma X; Marion DW
J Neurotrauma; 1997 Mar; 14(3):161-9. PubMed ID: 9104933
[TBL] [Abstract][Full Text] [Related]
23. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
Agut J; Font E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
[TBL] [Abstract][Full Text] [Related]
24. The use of cholinergic precursors in neuropsychiatric diseases.
Rosenberg GS; Davis KL
Am J Clin Nutr; 1982 Oct; 36(4):709-20. PubMed ID: 6214943
[TBL] [Abstract][Full Text] [Related]
25. Specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats.
Cansev M; van Wijk N; Turkyilmaz M; Orhan F; Sijben JW; Broersen LM
Neurobiol Aging; 2015 Jan; 36(1):344-51. PubMed ID: 25146455
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
27. Choline supplements: An update.
Kansakar U; Trimarco V; Mone P; Varzideh F; Lombardi A; Santulli G
Front Endocrinol (Lausanne); 2023; 14():1148166. PubMed ID: 36950691
[TBL] [Abstract][Full Text] [Related]
28. Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.
Gaudin M; Panchal M; Auzeil N; Duyckaerts C; Brunelle A; Laprévote O; Touboul D
Bioanalysis; 2012 Sep; 4(17):2153-5159. PubMed ID: 23013397
[TBL] [Abstract][Full Text] [Related]
29. Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial.
Carotenuto A; Andreone V; Amenta F; Traini E
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929542
[No Abstract] [Full Text] [Related]
30. Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.
Satlin A; Bodick N; Offen WW; Renshaw PF
Am J Psychiatry; 1997 Oct; 154(10):1459-61. PubMed ID: 9326834
[TBL] [Abstract][Full Text] [Related]
31. The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease.
Ehrenstein G; Galdzicki Z; Lange GD
Biophys J; 1997 Sep; 73(3):1276-80. PubMed ID: 9284295
[TBL] [Abstract][Full Text] [Related]
32. Nutrition and Alzheimer's disease: pre-clinical concepts.
Kamphuis PJ; Wurtman RJ
Eur J Neurol; 2009 Sep; 16 Suppl 1():12-8. PubMed ID: 19703215
[TBL] [Abstract][Full Text] [Related]
33. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
34. Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
Scapicchio PL
Int J Neurosci; 2013 Jul; 123(7):444-9. PubMed ID: 23387341
[TBL] [Abstract][Full Text] [Related]
35. Lecithin and choline in human health and disease.
Canty DJ; Zeisel SH
Nutr Rev; 1994 Oct; 52(10):327-39. PubMed ID: 7816350
[TBL] [Abstract][Full Text] [Related]
36. The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies.
Amenta F; Di Tullio MA; Tomassoni D
Clin Exp Hypertens; 2002; 24(7-8):697-713. PubMed ID: 12450245
[TBL] [Abstract][Full Text] [Related]
37. Acetylcholine synthesis and release in NIH3T3 cells coexpressing the high-affinity choline transporter and choline acetyltransferase.
Fujii T; Masai M; Misawa H; Okuda T; Takada-Takatori Y; Moriwaki Y; Haga T; Kawashima K
J Neurosci Res; 2009 Oct; 87(13):3024-32. PubMed ID: 19405101
[TBL] [Abstract][Full Text] [Related]
38. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
39. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons.
Wurtman RJ
Trends Neurosci; 1992 Apr; 15(4):117-22. PubMed ID: 1374967
[TBL] [Abstract][Full Text] [Related]
40. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
